Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

Aquestive Works with FDA to Resolve Hurdles for its New Sublingual Epinephrine Candidate

Hope on the Horizon: Ten Food Allergy Research Breakthroughs in 2025

Very Low-Dose Multi-Nut OIT Promising for Children with Multiple Food Allergies

DBV to Submit FDA Application After Viaskin Peanut Patch Achieves Goals in Phase 3 Trial

Mabylon Begins Human Clinical Trials of New Peanut Allergy Treatment

FDA Removes Hold Allowing DBV’s Pivotal Phase 3 Peanut Patch Trial...

Allakos Announces New Antibody that Prevents Anaphylaxis in Humanized Mice

Skin Patch Immunotherapy Determined Safe and Effective in Toddlers With Peanut...

Needle-Free, Sublingual Epinephrine Film Works Faster Than Auto-Injectors According to Study

Biologic Showing Promise as Food Allergy Treatment in Ongoing Phase 3...

Intrommune’s Toothpaste Immunotherapy for Peanut Allergy Completes Phase 1 Enrollment

FDA Accepts New Drug Application for Nasal Epinephrine Spray Treatment for...

Aquestive Receives Positive FDA Response to Epinephrine Sublingual Film Phase 2...

Gene Therapy Successfully Treats Mice with Food Allergies

Aquestive’s Sublingual Emergency Epinephrine Compares Favorably to EpiPen® in EPIPHAST II...

Your School On Our Map

Put Your School on the Map